Loading...
Loading...
ACST| Name | Value |
|---|---|
| Revenues | 0.0K |
| Cost of Revenue | 3,043.0K |
| Gross Profit | -3,043.0K |
| Operating Expense | 3,043.0K |
| Operating I/L | -3,043.0K |
| Other Income/Expense | 1,432.9K |
| Interest Income | 316.0K |
| Pretax | -2,599.0K |
| Income Tax Expense | -208.0K |
| Net Income/Loss | -2,391.0K |
Acasti Pharma Inc. is a biopharmaceutical company specializing in the development and commercialization of pharmaceutical products for cardiovascular diseases. The company's primary focus is on the clinical development of CaPre, a potential treatment for cardiovascular conditions. Acasti Pharma Inc. generates revenue through strategic partnerships and the eventual commercialization of its pharmaceutical products.
